関連する実験動画
Updated: Sep 8, 2025
14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
7.4K
ステロイド未使用の成人の気管性喘息におけるオシロメトリーで定義された小呼吸器機能障害:エオシノフィルおよび非エオシノフィル現象との関連
1Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
まとめ
小型の呼吸器機能障害 (SAD) は,新たに診断された喘息患者の半数に影響します. 非エオシノフィル性喘息のフェノタイプは,より大きな振動測定障害を示し,異なる疾患の特徴を示唆する.
科学分野:
- 呼吸器医学
- 肺科
- 喘息に関する研究
背景:
- 小型の呼吸道機能障害 (SAD) は,支氣管喘息ではよく見られるが,特定の喘息現象との関連は不明である.
- 喘息のフェノタイプとSADの関連性を理解することは,標的型治療戦略にとって極めて重要です.
研究 の 目的:
- ステロイド投与前の成人喘息患者のオシロメトリーによるSADの有病率を決定する.
- 外周血液のエオシノフィール数 (BEC) に基づいてSADと喘息のフェノタイプとの関連を調査する.
主な方法:
- 320人の成人喘息患者は,ASDのオシロメトリーを用いて評価された.
- 患者はBECに基づいてエオシノフィル性喘息 (EA) と非エオシノフィル性喘息 (NEA) に分類された.
- SADは特定のオシロメトリーパラメータ (R5 - 19とX5) によって定義され,zスコアを使用した.
主要な成果:
- SADは54. 4%の患者で検出された.
- コホートは58. 4%のEAと41. 6%のNEAで構成されていました.
- スピロメトリーではEAとNEAの差異はなかったが,NEAではR5-19が有意に高かった (57. 9%対47. 6%,p=0. 04).
結論:
- ステロイド未使用の喘息患者の診断時にSADは一般的です.
- 非エオシノフィル性喘息のフェノタイプは,オシロメトリーで検出されるより大きな小呼吸道障害と関連しています.
関連する概念動画
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446